Position in ASND
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$27,555,643
New position
Shares Held
103,313
first reported quarter
Ownership
0.158%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#67
of 307 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 46%
Shared 23%
None 31%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fiera Capital Corp holds $542,965,678 across 19 Biotechnology names. ASND ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
843,042 | $89,885,137 | |
| 2 | ARGX |
Argenx SE
|
90,423 | $83,891,746 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
1,445,885 | $53,888,133 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
99,857 | $53,618,215 | |
| 5 | QURE |
uniQure N.V.
|
909,141 | $41,875,034 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
516,997 | $29,370,599 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
103,313 | $27,555,643 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
405,638 | $24,484,308 |
All Filings in ASND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,555,643 | 103,313 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||